RE: Feelin' Blue9 Apr 2025 18:43
Porky, thought you might say that and funny how you and Viera both post at exactly 17.57! LOL
Well I won't be doing that I am sorry to say for you, as with the warrants exercised which only needs a half decent RNS we get the magical exercise price 0f 1.3p, but a few fact checks are in order as you appear confused somewhat.
Firstly, the new monies from the placing arrived in the coffers January 2025 and the new issued shares traded from 31st December 2024, so I don't know why you keep referring to September as the 'D-Day'?
Secondly, you obviously don't understand how warrants work so let me explain in laypersons terms for you....
Lets say the price gets to where you say and investors will cut and run at 5% profit, so that's 1.365p.
When they sell, a buyer takes the shares so the shares have simply changed hands, so at this juncture we have a market cap of 374mn shares x 1.36p = £5.1mn.... got it so far?
Then they exercise (the whole lot for arguments sake, although they have 3 years of coursen to exercise) 242mn shares at 1.3p which raises £3.15mn, so the theoretically the ex-warrant price is therefore.....
£8.25mn / 616 mn shares in issue = 1.34p per share PLUS the feel good factor by the market should propel this much higher TBH from my experience.
So hardly any change to existing PI's whatsoever unlike you say.
The golden egg that is laid by VAL allows it to pursue its project and particularly CLX (expected commercially ready EOY) which should in theory provide in its entirety, an 8 or 9 figure deal if it's as as good as expected (RNS cliniucal update TBC we are told) as ME states and in the presentation a median of £40mn CASH upfront which alone is 6.5p per share fully diluted or multiples of this if you want to price in the total package, but we don't want to get ahead of ourselves do we.
Then add in 401, 201, lab income, Stingray, any new evaluations or SPV's etc. and we have a sound and fully supportive business model.
Herein ends the lesson!
GLA, NAI, DYOR